Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 4.5B | 4.9B | 8.4B |
Cost of revenue | 4.1B | 2.4B | 2.6B | 3.7B |
Gross profit | 5.0B | 2.2B | 2.3B | 4.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 586M | 634M | 1.2B |
Other operating expenses | 1.3B | 1.0B | 1.0B | 1.3B |
Operating income | 1.8B | 93M | 147M | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 42M | 33M | 9M | 36M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 101M | 237M | 1.5B |
Tax provision | 15M | 37M | 28M | 39M |
Net income | 1.7B | 64M | 209M | 1.5B |
Basic EPS | — | 1.0 | 3.3 | 23.2 |
Diluted EPS | — | 1.0 | 3.3 | 23.2 |
Basic average shares | — | 63.4M | 63.7M | 63.6M |
Diluted average shares | — | 63.4M | 63.7M | 63.6M |
EBITDA | 1.9B | 186M | 236M | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |